Sumitomo Mitsui Trust Group
VCYT icon

Sumitomo Mitsui Trust Group’s Veracyte VCYT Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.2M Sell
768,949
-286,707
-27% -$12M 0.03% 487
2026
Q1 		$34M Sell
1,055,656
-202,242
-16% -$7.49M 0.02% 543
2025
Q4 		$53M Sell
1,257,898
-224,185
-15% -$9.04M 0.03% 447
2025
Q3 		$50.9M Sell
1,482,083
-165,094
-10% -$4.74M 0.03% 470
2025
Q2 		$44.5M Sell
1,647,177
-616,762
-27% -$17.9M 0.03% 482
2025
Q1 		$67.1M Sell
2,263,939
-229,438
-9% -$8.75M 0.05% 365
2024
Q4 		$98.7M Sell
2,493,377
-259,006
-9% -$9.81M 0.07% 282
2024
Q3 		$93.7M Sell
2,752,383
-429,209
-13% -$12.1M 0.06% 297
2024
Q2 		$68.9M Sell
3,181,592
-165,844
-5% -$3.49M 0.05% 353
2024
Q1 		$74.2M Buy
3,347,436
+242,760
+8% +$5.92M 0.05% 381
2023
Q4 		$85.4M Sell
3,104,676
-68,900
-2% -$1.66M 0.06% 332
2023
Q3 		$70.9M Sell
3,173,576
-75,437
-2% -$1.94M 0.06% 358
2023
Q2 		$82.8M Sell
3,249,013
-46,103
-1% -$1.12M 0.06% 326
2023
Q1 		$73.5M Buy
3,295,116
+230,671
+8% +$5.58M 0.05% 379
2022
Q4 		$72.7M Buy
3,064,445
+60,527
+2% +$1.41M 0.06% 383
2022
Q3 		$49.9M Buy
3,003,918
+82,440
+3% +$1.86M 0.04% 484
2022
Q2 		$58.1M Sell
2,921,478
-93,563
-3% -$1.89M 0.04% 452
2022
Q1 		$83.1M Sell
3,015,041
-106,062
-3% -$3.03M 0.06% 377
2021
Q4 		$129M Buy
3,121,103
+164,724
+6% +$7.28M 0.08% 275
2021
Q3 		$137M Sell
2,956,379
-211,859
-7% -$9.24M 0.09% 257
2021
Q2 		$127M Sell
3,168,238
-91,284
-3% -$3.9M 0.07% 293
2021
Q1 		$175M Sell
3,259,522
-12,516
-0.4% -$721K 0.11% 206
2020
Q4 		$160M Buy
3,272,038
+288,583
+10% +$13.4M 0.1% 218
2020
Q3 		$96.9M Sell
2,983,455
-161,731
-5% -$5.14M 0.07% 315
2020
Q2 		$81.5M Sell
3,145,186
-142,281
-4% -$3.54M 0.06% 358
2020
Q1 		$79.9M Buy
3,287,467
+234,216
+8% +$5.9M 0.07% 315
2019
Q4 		$85.2M Buy
3,053,251
+289,015
+10% +$7.48M 0.07% 312
2019
Q3 		$66.3M Buy
2,764,236
+1,633,287
+144% +$43.4M 0.06% 356
2019
Q2 		$32.2M Buy
1,130,949
+534,049
+89% +$13.3M 0.03% 562
2019
Q1 		$14.9M Buy
+596,900
New +$11.4M 0.01% 670

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sumitomo Mitsui Trust Group's VCYT Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group reduced its Veracyte (VCYT) stake by 27% in Q2 2026, selling an estimated $12M and leaving 768,949 shares worth $45.2M. The position accounts for 0.03% of the portfolio, ranked #487.

Sumitomo Mitsui Trust Group first reported a position in VCYT in Q1 2019 and has held it in 30 quarters since. The position peaked at $175M in Q1 2021. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 768,949 shares of Veracyte worth $45.2M as of Q2 2026.
  • Sumitomo Mitsui Trust Group sold 286,707 Veracyte shares in Q2 2026, an estimated $12M.
  • Veracyte made up 0.03% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #487 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Veracyte in Q1 2019 and has held it in 30 quarters since.
  • Sumitomo Mitsui Trust Group's Veracyte position peaked at $175M in Q1 2021.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.